Literature DB >> 7428583

Peptic ulceration in patients with chronic liver disease.

A P Kirk, J S Dooley, R H Hunt.   

Abstract

A prospective study was undertaken to determine the frequency of peptic ulceration in different forms of chronic liver disease and the effect of corticosteroid treatment. One hundred sixty-three patients with chronic liver disease underwent upper gastrointestinal endoscopy, 106 for investigation of dyspeptic symptoms and the remaining 57 for assessment of the presence of varices. Twenty-four peptic ulcers were found (14.7%), 12 duodenal, 8 gastric, and 4 prepyloric. Ulcers were found in 5 of 15 patients with hepatitis B surface-antigen-positive chronic active liver disease (33%), 10 of 46 patients with alcoholic liver disease (22%), 5 of 35 with primary biliary cirrhosis (14%), 2 of 19 with miscellaneous chronic liver diseases (10%), and 2 of 25 with cryptogenic cirrhosis (8%). Ulcers were not demonstrated in any of the 23 patients with hepatitis B surface-antigen-negative chronic active hepatitis. Thirty-one patients were receiving prednisolone therapy, 5 had peptic ulcer compared with 19 of the remaining 132 patients. This difference was not significant. Fifty-nine patients presented with gastrointestinal bleeding on 88 separate occasions. Peptic ulcer was the cause in 6% of these. In chronic liver disease peptic ulcers occurred with differing frequencies in different forms of the disease. This was unaffected by corticosteroid therapy. Peptic ulcers were rarely the cause of gastrointestinal bleeding.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428583     DOI: 10.1007/bf01345294

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  PEPTIC ULCER AND GASTRIC SECRETION IN PATIENTS WITH LIVER DISEASE.

Authors:  S TABAQCHALI; A M DAWSON
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

2.  Sources of upper gastrointestinal hemorrhage in cirrhotic patients with esophageal varices.

Authors:  E D PALMER; I B BRICK
Journal:  N Engl J Med       Date:  1953-06-18       Impact factor: 91.245

Review 3.  Nonassociation of adrenocorticosteroid therapy and peptic ulcer.

Authors:  H O Conn; B L Blitzer
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

Review 4.  Peptic ulcer. A medical perspective.

Authors:  M L Chapman
Journal:  Med Clin North Am       Date:  1978-01       Impact factor: 5.456

5.  Prednisone side-effects and serum-protein levels. A collaborative study.

Authors:  G P Lewis; W J Jusko; L Graves; C W Burke
Journal:  Lancet       Date:  1971-10-09       Impact factor: 79.321

6.  Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases.

Authors: 
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

7.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

8.  The diagnosis of the site of upper gastrointestinal haemorrhage in patients with established portal hypertension.

Authors:  C J Mitchell; D P Jewell
Journal:  Endoscopy       Date:  1977-08       Impact factor: 10.093

9.  Portacaval anastomosis and peptic ulcer: a nonassociation.

Authors:  M M Phillips; G R Ramsey; H O Conn
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

10.  Emergency endoscopy after gastrointestinal haemorrhage in 50 patients with portal hypertension.

Authors:  R Waldram; M Davis; H Nunnerley; R Williams
Journal:  Br Med J       Date:  1974-10-12
View more
  14 in total

Review 1.  Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review.

Authors:  M Kalafateli; C K Triantos; V Nikolopoulou; A Burroughs
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone.

Authors:  T Iwao; A Toyonaga; M Ikegami; H Shigemori; K Oho; M Sumino; K Tanikawa
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

4.  Frequent non-response to histamine H2-receptor antagonists in cirrhotics.

Authors:  S Walker; D R Krishna; U Klotz; J C Bode
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

5.  Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients.

Authors:  M Morichau-Beauchant; G Houin; P Mavier; C Alexandre; D Dhumeaux
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

6.  High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer.

Authors:  S Siringo; D Vaira; M Menegatti; F Piscaglia; S Sofia; M Gaetani; M Miglioli; R Corinaldesi; L Bolondi
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

7.  Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study.

Authors:  J J Chen; C S Changchien; D I Tai; S S Chiou; C M Lee; C H Kuo
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

Review 8.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

9.  Prevalence of duodenal ulcer in cirrhotic males referred for liver transplantation. Does the etiology of cirrhosis make a difference?

Authors:  M Rabinovitz; R R Schade; V Dindzans; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

10.  Associations of peptic ulcer and gastric cancer with other diseases in US veterans.

Authors:  A Sonnenberg; I H Wasserman
Journal:  Am J Public Health       Date:  1995-09       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.